• Fate Therapeutics appointed Jamie Harrell as senior vice president, market development and commercial operations, effective Oct. 12, 2026.
• Harrell will lead commercial and market development strategy across autoimmunity and oncology as the company moves toward commercialization.
• His remit includes physician engagement tied to outpatient administration for off-the-shelf CAR T programs, including FT819 and FT839.
• Harrell previously served as vice president of marketing and commercial operations at Aurinia Pharmaceuticals.
• Earlier roles include chief commercial officer at Avalo Therapeutics, vice president and general manager at Covidien, with prior leadership posts at MedImmune, Centocor, Rhone-Poulenc Rorer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fate Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610120700PRIMZONEFULLFEED9843255) on October 12, 2026, and is solely responsible for the information contained therein.